{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:49:51Z","timestamp":1788187791389,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.annder.2018.04.007","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T18:57:30Z","timestamp":1526583450000},"page":"607-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Carcinome \u00e9pidermo\u00efde de croissance rapide apr\u00e8s traitement par m\u00e9butate d\u2019ing\u00e9nol"],"prefix":"10.1016","volume":"145","author":[{"given":"M.","family":"Ehret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Velter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tebacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bruant-Rodier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cribier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.04.007_bib0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2000.103339","article-title":"The risk of progression to invasive disease","volume":"42","author":"Glogau","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2018.04.007_bib0130","first-page":"741","article-title":"Efficacy and safety of ingenol mebutate 0.015\u00a0% gel after cryosurgery of actinic keratosis: 12-month results","volume":"13","author":"Berman","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.annder.2018.04.007_bib0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jdv.14092","article-title":"The importance of treating the field in actinic keratosis","volume":"31","author":"Stockfleth","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.04.007_bib0140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2006.07692.x","article-title":"British association of dermatologists therapy. Guidelines for the management of actinic keratosesguidelines and audit subcommittee","volume":"156","author":"de Berker","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2018.04.007_bib0145","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/S0151-9638(09)75170-1","article-title":"Carcinome \u00e9pidermo\u00efde cutan\u00e9 (carcinome spinocellulaire). Recommandations de pratique clinique pour la prise en charge diagnostique et th\u00e9rapeutique","volume":"136","author":"Martin","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.04.007_bib0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3315\/jdcr.2015.1199","article-title":"How to treat actinic keratosis? An update","volume":"9","author":"Costa","year":"2015","journal-title":"J Dermatol Case Rep"},{"key":"10.1016\/j.annder.2018.04.007_bib0155","unstructured":"Fiche Avis nouveau m\u00e9dicament\u2013synthese_picato_pdf_131002.pdf [Internet]. Disponible sur\u00a0: https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2013-10\/synthese_picato_pdf_131002.pdf [consult\u00e9 le 2017\u00a0Sep 11]."},{"key":"10.1016\/j.annder.2018.04.007_bib0160","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1158\/1535-7163.MCT-15-0023-T","article-title":"Ingenol mebutate signals via PKC\/MEK\/ERK in Keratinocytes and induces interleukin decoy receptors IL1R2\u00a0and IL13RA2","volume":"14","author":"Freiberger","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.annder.2018.04.007_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153975","article-title":"IL-1\u00a0Contributes to the anti-cancer efficacy of ingenol mebutate","volume":"11","author":"Le","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.annder.2018.04.007_bib0170","first-page":"69","article-title":"Cryosurgery\u00a0\u2013\u00a0a review of recent advances and current issues","volume":"23","author":"Gage","year":"2002","journal-title":"Cryo Letters"},{"key":"10.1016\/j.annder.2018.04.007_bib0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.08265.x","article-title":"Imiquimod: mode of action","volume":"157","author":"Sch\u00f6n","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2018.04.007_bib0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/09546634.2010.507704","article-title":"Mechanisms of action of topical 5-fluorouracil: review and implications for the treatment of dermatological disorders","volume":"23","author":"Ceilley","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2018.04.007_bib0185","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","article-title":"Ingenol mebutate gel for actinic keratosis","volume":"366","author":"Lebwohl","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2018.04.007_bib0190","unstructured":"Picato, ingenol mebutate \u2013 WC500135329.pdf [Internet]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_Public_assessment_report\/human\/002275\/WC500135329.pdf [cited 2017 Sep 11]."},{"key":"10.1016\/j.annder.2018.04.007_bib0195","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/hed.24580","article-title":"Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American joint committee on cancer and NCCN clinical practice guidelines in oncology","volume":"39","author":"Skulsky","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.annder.2018.04.007_bib0200","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jamadermatol.2017.1680","article-title":"Clinical and incidental perineural invasion of cutaneous squamous cell carcinoma: a systematic review and pooled analysis of outcomes data","volume":"153","author":"Karia","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annder.2018.04.007_bib0205","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ad.2011.12.019","article-title":"Cutaneous squamous cell carcinoma: defining the high-risk variant","volume":"104","author":"Martorell-Calatayud","year":"2013","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.annder.2018.04.007_bib0210","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/bjd.14054","article-title":"Rapidly growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two cases","volume":"173","author":"Moreno Romero","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2018.04.007_bib0215","doi-asserted-by":"crossref","first-page":"AB196","DOI":"10.1016\/j.jaad.2016.02.771","article-title":"Development of squamous cell carcinoma on actinic keratosis after ingenol mebutate (Picato@) gel)","volume":"74","author":"Seung Hee Loh","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2018.04.007_bib0220","unstructured":"Base de donn\u00e9es europ\u00e9enne des rapports d\u2019effets ind\u00e9sirables susceptibles d\u2019\u00eatre li\u00e9s \u00e0 l\u2019utilisation de m\u00e9dicaments. Disponible sur\u00a0: http:\/\/www.adrreports.eu\/fr\/search.html# [consult\u00e9 le 07\u00a0septembre 2017]."},{"key":"10.1016\/j.annder.2018.04.007_bib0225","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.annder.2015.03.027","article-title":"Apparition rapide d\u2019un carcinome \u00e9pidermo\u00efde sur le site donneur d\u2019une greffe de peau mince","volume":"143","author":"Herard","year":"2016","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.04.007_bib0230","doi-asserted-by":"crossref","first-page":"771","DOI":"10.36076\/ppj.2007\/10\/771","article-title":"Squamous cell carcinoma occurring within incision of recently implanted spinal cord stimulator","volume":"10","author":"Atallah","year":"2007","journal-title":"Pain Physician"},{"key":"10.1016\/j.annder.2018.04.007_bib0235","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaad.2009.01.037","article-title":"Eruptive postoperative squamous cell carcinomas exhibiting a pathergy-like reaction around surgical wound sites","volume":"61","author":"Bangash","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2018.04.007_bib0120","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/bjd.13036","article-title":"Development of squamous cell carcinoma after photodynamic therapy with methyl aminoleuvulinate","volume":"171","author":"Calista","year":"2014","journal-title":"Br J Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818303922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818303922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:06:28Z","timestamp":1758971188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963818303922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0151963818303922"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.04.007","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carcinome \u00e9pidermo\u00efde de croissance rapide apr\u00e8s traitement par m\u00e9butate d\u2019ing\u00e9nol","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}